Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer

The objective of this study was to investigate the clinical value of exhaled nitric oxide (NO) for diagnosing lung cancer patients by using a relatively large sample. An online and near-real-time ringdown exhaled NO analyzer calibrated by an electrochemical sensor at clinical was used for breath ana...

Full description

Bibliographic Details
Main Authors: Jing Li, Qingyuan Li, Xin Wei, Qing Chen, Meixiu Sun, Yingxin Li
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/11/6/352
_version_ 1797531832060739584
author Jing Li
Qingyuan Li
Xin Wei
Qing Chen
Meixiu Sun
Yingxin Li
author_facet Jing Li
Qingyuan Li
Xin Wei
Qing Chen
Meixiu Sun
Yingxin Li
author_sort Jing Li
collection DOAJ
description The objective of this study was to investigate the clinical value of exhaled nitric oxide (NO) for diagnosing lung cancer patients by using a relatively large sample. An online and near-real-time ringdown exhaled NO analyzer calibrated by an electrochemical sensor at clinical was used for breath analysis. A total of 740 breath samples from 284 healthy control subjects (H) and 456 lung cancer patients (LC) were collected. The recorded data included exhaled NO, medications taken within the last half month, demographics, fasting status and smoking status. The LC had a significantly higher level of exhaled NO than the H (H: 21.0 ± 12.1 ppb vs. LC: 34.1 ± 17.2 ppb). The area under the receiver operating characteristic curve for exhaled NO predicting LC and H was 0.728 (sensitivity was 0.798; specificity was 0.55). There was no significant difference in exhaled NO level between groups divided by different types of LC, tumor node metastasis (TNM) stage, sex, smoking status, age, body mass index (BMI) or fasting status. Exhaled NO level alone is not a useful clinical tool for identifying lung cancer, but it should be considered when developing a diagnosis model of lung cancer by using breath analysis.
first_indexed 2024-03-10T10:50:23Z
format Article
id doaj.art-07209316adee46d39af4c14ab06475e7
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-10T10:50:23Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-07209316adee46d39af4c14ab06475e72023-11-21T22:16:56ZengMDPI AGMetabolites2218-19892021-05-0111635210.3390/metabo11060352Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO AnalyzerJing Li0Qingyuan Li1Xin Wei2Qing Chen3Meixiu Sun4Yingxin Li5Institute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 100730, ChinaInstitute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 100730, ChinaInstitute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 100730, ChinaNational Clinical Research Center for Cancer, Deparment of Cardio-Pulmonary Function, Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300070, ChinaInstitute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 100730, ChinaInstitute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 100730, ChinaThe objective of this study was to investigate the clinical value of exhaled nitric oxide (NO) for diagnosing lung cancer patients by using a relatively large sample. An online and near-real-time ringdown exhaled NO analyzer calibrated by an electrochemical sensor at clinical was used for breath analysis. A total of 740 breath samples from 284 healthy control subjects (H) and 456 lung cancer patients (LC) were collected. The recorded data included exhaled NO, medications taken within the last half month, demographics, fasting status and smoking status. The LC had a significantly higher level of exhaled NO than the H (H: 21.0 ± 12.1 ppb vs. LC: 34.1 ± 17.2 ppb). The area under the receiver operating characteristic curve for exhaled NO predicting LC and H was 0.728 (sensitivity was 0.798; specificity was 0.55). There was no significant difference in exhaled NO level between groups divided by different types of LC, tumor node metastasis (TNM) stage, sex, smoking status, age, body mass index (BMI) or fasting status. Exhaled NO level alone is not a useful clinical tool for identifying lung cancer, but it should be considered when developing a diagnosis model of lung cancer by using breath analysis.https://www.mdpi.com/2218-1989/11/6/352exhaled NOlung cancerbreath biomarkerscavity ringdown spectroscopy (CRDS)
spellingShingle Jing Li
Qingyuan Li
Xin Wei
Qing Chen
Meixiu Sun
Yingxin Li
Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer
Metabolites
exhaled NO
lung cancer
breath biomarkers
cavity ringdown spectroscopy (CRDS)
title Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer
title_full Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer
title_fullStr Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer
title_full_unstemmed Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer
title_short Measurement of Exhaled Nitric Oxide in 456 Lung Cancer Patients Using a Ringdown FENO Analyzer
title_sort measurement of exhaled nitric oxide in 456 lung cancer patients using a ringdown feno analyzer
topic exhaled NO
lung cancer
breath biomarkers
cavity ringdown spectroscopy (CRDS)
url https://www.mdpi.com/2218-1989/11/6/352
work_keys_str_mv AT jingli measurementofexhalednitricoxidein456lungcancerpatientsusingaringdownfenoanalyzer
AT qingyuanli measurementofexhalednitricoxidein456lungcancerpatientsusingaringdownfenoanalyzer
AT xinwei measurementofexhalednitricoxidein456lungcancerpatientsusingaringdownfenoanalyzer
AT qingchen measurementofexhalednitricoxidein456lungcancerpatientsusingaringdownfenoanalyzer
AT meixiusun measurementofexhalednitricoxidein456lungcancerpatientsusingaringdownfenoanalyzer
AT yingxinli measurementofexhalednitricoxidein456lungcancerpatientsusingaringdownfenoanalyzer